Other Species / Isoforms
  PLB (rat)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K3
_____MEKVQYLTRS
1 1
PLB (human) _____MEKVQYLTRS K3
PLB (mouse) _____MEkVQYLTRS K3-ub
PLB (rat) _____MEKVQYLTRS K3
PLB (rabbit) _____MEKVQYLTRS K3
PLB (pig) _____MDKVQYLTRS K3
PLB (dog) _____MDKVQYLTRS K3
K3-ac
_____MEkVQYLTRS
0 1
PLB (human) _____MEKVQYLTRS K3
PLB (mouse) _____MEKVQYLTRS K3
PLB (rat) _____MEkVQYLTRS K3-ac
PLB (rabbit) _____MEKVQYLTRS K3
PLB (pig) _____MDKVQYLTRS K3
PLB (dog) _____MDKVQYLTRS K3
S16-p
RSAIRRAstIEMPQQ
Upstream
Downstream
81 81
PLB (human)
S16-p
PLB (mouse)
S16-p
PLB (rat)
S16-p
PLB (rabbit)
S16-p
PLB (pig)
S16-p
PLB (dog)
S16-p
Effects on Modified Protein
  • activity, induced
  • enzymatic activity, induced
Kinase, in vitro:
  • Akt1 (human)
Putative in vivo kinases:
  • Akt1 (rat)
  • PKACA (rat)
Putative upstream phosphatases:
  • PPP1CA (human)
Regulatory protein:
  • ADCY6 (mouse)
  • Akt1 (human)
  • PMCA4 iso2 (human)
  • PRKD1 (mouse)
view more >
Treatment
  • 5-Methoxytryptophan
  • 8-Rp-cAMP
  • acidosis
  • Akt-I-1
  • Akt-I-1,2
  • aortic banding
  • azaserine
  • Bay 60-7550
  • bradykinin
  • Ca(2+)
  • cariporide
  • ciclosporin
  • cigarette smoke extract
  • colforsin
  • CPA
  • electrical_stimulation
  • empagliflozin
  • endothelin
  • exercise
  • exercise training
  • FK506
  • Go_6976
  • H-89
  • high_glucose
  • hypertension
  • ibrutinib
  • ICI-118,551
  • inhibitor-1
  • ischemia
  • ischemia/reperfusion
  • isoproterenol
  • ketogenic diet
  • liothyronine
  • low_pH
  • nifedipine
  • norepinephrine
  • obesity
  • okadaic_acid
  • PKI
  • prazosin
  • pressure
  • propranolol
  • PUGNAc
  • resistance training
  • serum
  • SMLT
  • streptozotocin
view more >
PLB (human) RSAIRRAstIEMPQQ S16-p
PLB (mouse) RSAIRRAstIEMPQQ S16-p
PLB (rat) RSAIRRAstIEMPQQ S16-p
PLB (rabbit) RSAIRRAstIEMPQQ S16-p
PLB (pig) RSAIRRAsTIEMPQQ S16-p
PLB (dog) RSAIRRAstIEMPQQ S16-p
S16-gl
RSAIRRAstIEMPQQ
Upstream
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Treatment
  • azaserine
  • high_glucose
  • PUGNAc
  • streptozotocin
view more >
PLB (human) RSAIRRAStIEMPQQ S16
PLB (mouse) RSAIRRAStIEMPQQ S16
PLB (rat) RSAIRRAstIEMPQQ S16-gl
PLB (rabbit) RSAIRRAStIEMPQQ S16
PLB (pig) RSAIRRASTIEMPQQ S16
PLB (dog) RSAIRRAStIEMPQQ S16
T17-p
SAIRRAstIEMPQQA
Upstream
Downstream
74 75
PLB (human)
T17-p
PLB (mouse)
T17-p
PLB (rat)
T17-p
PLB (rabbit)
T17-p
PLB (pig)
T17-p
PLB (dog)
T17-p
Effects on Modified Protein
  • activity, induced
Putative in vivo kinases:
  • CAMK2D (rat)
Putative upstream phosphatases:
  • PPP1CA (human)
Regulatory protein:
  • ADCY6 (human)
  • ADCY6 (mouse)
  • Calmodulin (human)
  • CAMK2A (human)
  • CAMK2B (human)
view more >
Treatment
  • 5-Methoxytryptophan
  • acidosis
  • aortic banding
  • autocamtide_inhibitory_peptide
  • Ba(2+)
  • Bay 60-7550
  • bradykinin
  • Ca(2+)
  • calyculin_A
  • ciclosporin
  • cigarette smoke extract
  • colforsin
  • electrical_stimulation
  • exercise
  • exercise training
  • FK506
  • Go_6976
  • H-89
  • hypertension
  • ibrutinib
  • inhibitor-1
  • ionomycin
  • ischemia
  • ischemia/reperfusion
  • isoproterenol
  • KBR
  • KN-93
  • liothyronine
  • low_Ca(2+)
  • myocarditis
  • nifedipine
  • norepinephrine
  • okadaic_acid
  • prazosin
  • prednisolone
  • pressure
  • W-7
  • zacopride
view more >
PLB (human) SAIRRAstIEMPQQA T17-p
PLB (mouse) SAIRRAstIEMPQQA T17-p
PLB (rat) SAIRRAstIEMPQQA T17-p
PLB (rabbit) SAIRRAstIEMPQQA T17-p
PLB (pig) SAIRRAsTIEMPQQA T17
PLB (dog) SAIRRAstIEMPQQA T17-p